Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale.
about
Advances in cancer vaccine development.Natural and induced human antibody response to cancer.Anti-cancer properties of gastropodan hemocyanins in murine model of colon carcinoma.Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trialPolyclonal antibodies from patients immunized with a globo H-keyhole limpet hemocyanin vaccine: isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens.Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive SystemLipopeptide-Coated Iron Oxide Nanoparticles as Potential Glycoconjugate-Based Synthetic Anticancer Vaccines.Recent Development in Carbohydrate Based Anti-cancer Vaccines.Tumor-Associated Glycans and Immune SurveillanceImproving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccinesSynthetic and immunological studies of 5'-N-phenylacetyl sTn to develop carbohydrate-based cancer vaccines and to explore the impacts of linkage between carbohydrate antigens and carrier proteinsSpecificity in cancer immunotherapy.A new model for the presentation of tumor-associated antigens and the quest for an anticancer vaccine: a solution to the synthesis challenge via ring-closing metathesis.Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumors.Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience.Common antigens between hydatid cyst and cancersAnti-NeuGcGM3 reactivity: a possible role of natural antibodies and B-1 cells in tumor immunosurveillance.N-Glycolyl GM3 ganglioside immunoexpression in oral mucosal melanomas of Chinese.Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients.Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans.A new generation of carbohydrate-based therapeutics: recombinant mucin-type fusion proteins as versatile inhibitors of protein-carbohydrate interactions.Toxicity of a GM3 cancer vaccine in Macaca fascicularis monkey: a 12-month study.Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses.
P2860
Q33603404-58F4AFCD-7AB9-495A-BDE7-948D3F3E6FFBQ33931150-3A321C9D-47B9-433D-BE52-B6441D7764F8Q34184980-99760350-BDF7-4265-8E57-2B86D85B0937Q34720308-5DC5DCE3-4BED-4C49-9860-CF138E363369Q35079733-A15B4FF2-35EC-46F4-8DAE-E64818635E0EQ35200716-DD08CB58-4705-4A4D-BA91-490BDF757C9CQ35705462-9FD7A988-9413-46A8-80A2-9CC26308CB08Q35854131-913DF8A7-A7AE-4451-9DB0-83D50DEBE345Q35890610-32999D48-9B10-417B-BDF7-5EE1B681EBDFQ36868822-4BAFF7A2-37EE-4AB4-B9B2-DE2BEE13FB35Q37120643-5B41FCC1-3FFC-44DB-8D42-B48674059B61Q37236636-28705B48-1E5B-4147-B673-04DFB580383AQ37380026-B6394F94-BA63-441C-840C-DDAD937A4FDAQ37484024-A10F18C9-81AE-450A-B4C4-B90530729A70Q37608314-1CFCE35C-F36A-4708-A493-CB6975470906Q38673307-DA903EEC-100D-42F6-B8E9-61F2C291BFA1Q38848896-E9FDFAF3-FEFA-4F5F-B845-36E52B0C4CF4Q39350862-5D445554-65AC-4AE5-9086-783DDC7D71CFQ40801062-76B17651-00C5-4A91-B1A1-AF564E85B1E7Q40879087-FD5C4528-813E-43EF-9F28-47B9ABCE527DQ51171028-B31FFF85-EBF6-47F5-A91D-3EBB390C1B6CQ51709399-38815265-9686-47AC-B618-063005040293Q53892129-4FEDC70E-C7ED-44CB-9FF9-7314B6D72D54
P2860
Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale.
@en
type
label
Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale.
@en
prefLabel
Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale.
@en
P2093
P2860
P356
P1476
Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale.
@en
P2093
P2860
P2888
P356
10.1007/S002620050394
P577
1997-10-01T00:00:00Z
P6179
1044967217